RxDoctor Payments Data

Angela Zumer-Braatz

Physician Assistant · Duncansville, PANPI 1427220060

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 1,322 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 31.7% of the total. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,915in general payments, 2019–2025

Across 1,322 payments — averaging $14.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Amgen$3K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • UCB, Inc.$1K
  • Novartis$1K
  • plus $5K from 23 others

What the payments were for

  • Food & beverage$18,61498%
  • Education$3012%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,915 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept46$416,761
RinvoqUpadacitinib55$373,496
Humira(Cf) PenAdalimumab27$279,485
Xeljanz XrTofacitinib Citrate12$68,835
KevzaraSarilumab12$61,867
Hydroxychloroquine Sulfate339$17,523
MethotrexateMethotrexate Sodium360$10,156
Leflunomide47$2,430
Celecoxib87$2,123
Duloxetine Hcl90$2,073
Mycophenolate Mofetil13$1,194
Gabapentin79$1,106
Sulfasalazine48$1,061
Pilocarpine Hcl11$960
Prednisone155$940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$5,999$373,49655 claims
SanofiKevzara$445$61,86712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Duncansville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →